Horizon Therapeutics PLC (NASDAQ:HZNP)
| 106.19 BATS BZX Real-Time Price As of 12:27pm ET |  +0.12 / +0.11%Today’s Change | 66.41 Today|||52-Week Range 111.70 | +45.17% Year-to-Date |
Latest HZNP News | Press Releases
| Aerie (AERI) Announces Mixed Data From Dry Eye Disease Study 11:19am / Zacks.com - Paid Partner Content | Horizon (HZNP) Begins Phase IV Study on Tepezza for Chronic TED Sep 08 / Zacks.com - Paid Partner Content |
| Here's Why You Should Retain QIAGEN (QGEN) Stock For Now 9:38am / Zacks.com - Paid Partner Content | Here's Why Momentum Investors Will Love Horizon Therapeutics (HZNP) Sep 03 / Zacks.com - Paid Partner Content |
| 3 Reasons Why Horizon Therapeutics (HZNP) Is a Great Growth Stock Sep 15 / Zacks.com - Paid Partner Content | Why Is Horizon Therapeutics (HZNP) Up 3.7% Since Last Earnings Report? Sep 03 / Zacks.com - Paid Partner Content |
| Is Horizon (HZNP) a Great Growth Stock? Sep 14 / Zacks.com - Paid Partner Content | Techne (TECH) Soars to 52-Week High, Time to Cash Out? Sep 03 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 106.07 |
| Today’s open | 106.11 |
| Day’s range | 105.59 - 106.81 |
| Volume | 9,840 |
| Average volume (3 months) | 1,361,501 |
| Market cap | $24.3B |
Data as of 12:27pm ET, 09/16/2021
Growth & Valuation
| Earnings growth (last year) | -38.99% |
| Earnings growth (this year) | +16.52% |
| Earnings growth (next 5 years) | +18.07% |
| Revenue growth (last year) | +69.26% |
| P/E ratio | 43.3 |
| Price/Sales | 7.16 |
| Price/Book | 5.92 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CTLTCatalent Inc | +0.14 | +0.10% |
| ALNYAlnylam Pharmaceutic... | +0.99 | +0.53% |
| SGENSeagen Inc | -1.29 | -0.85% |
| VTRSViatris Inc | -0.07 | -0.51% |
Data as of 12:30pm ET, 09/16/2021
Financials
| Next reporting date | November 8, 2021 |
| EPS forecast (this quarter) | $1.54 |
| Annual revenue (last year) | $2.2B |
| Annual profit (last year) | $389.8M |
| Net profit margin | 17.71% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
